| Main Subject |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Customer Service > Retailers Face Credibility Problems |
|
Main Subject - Retailers Face Credibility Problems
It seems to have started harmlessly enough, this business of retailers misleading their customers. But after several years first of stretching the truth, then nibbling hungrily awa According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product y at it, it appears many retailers wouldn’t know the truth if they stepped in it. It began a decade or so ago, I’m told, apparently because of the “plumping” of America. Ladies cl ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in thing stores began being questioned by a growing number of women – no pun intended – about why their dresses and slacks didn’t seem to fit as comfortably as they once did. To be fa lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. r, we men were asking similar questions. “Fit” had apparently become much tighter, almost uncomfortably tight. The answer to poor fit with women’s clothing was for manufactures to here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe put a size 6 label on a size 10 garment. Those numbers may be off a bit, but the practice worked. And the ladies were happy because they could again fit into a “size 6.” For men, d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro ne answer was to create a line of roomier “comfort fit” jeans. I can’t swear those stories are true, but I’ve heard them repeated too many times from too many sources within the in ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc dustry for them not to have some basis in truth. Anyway, satisfied with those toe-in-the-water type of experiences, some retailers began stretching the truth even further, and in d easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi fferent ways. Low-end retailers – there’s no need to name them – began by placing orders with manufacturers for merchandise that was to be delivered pre-labeled with artificially h nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically gh prices. The practice at first involved only certain items such as hard goods and small electronics. Those retailers would then advertise these items at “discount savings” off t and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ eir phony high label prices. Better yet, when those “sales” were over, those items often sold at those inflated label prices, creating even more profit for the retailers. Deceptiv ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi ? Perhaps, but at that point only on a relatively small scale. At least for several years. But the trend has since blossomed, and with it have grown the types of items that are p ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a re-priced artificially high. Blossomed, too, have the number of retailers taking part in the deception. It’s no longer just low-end retailers who do it. The practice now includes dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod some of the largest retail chains in the country. Try this on for size. Who in their right mind would pay $49.95 for a mid-level retail chain’s private label, man’s all-cotton swe cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin ter – made in some far off country whose name you can’t spell and can only barely pronounce? No one with any shopping savvy, that’s for sure. But would you pay $25 for it during a tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen “Save 50%” sale? That’s what many retailers are doing, why many people fall into their trap. And it’s not just with men’s sweaters. My suggestion is to just walk away from those t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel sales.” Unless, of course, you see that the quality of that particular sweater – or any other item – is what you expect in a sweater that’s actually worth $25. Then you lose nothi ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust ng by paying the $25. But at that point what you’re buying is a sweater you know is worth $25. Don’t for a moment kid yourself – or let anyone else kid you – that you’re buying a y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products 49.95 sweater for $25. That practice of putting artificially high priced, pre-labeled merchandise “on sale” has spread well beyond clothing department stores. It has now infested . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de etail grocery chains as well. Sometimes with a unique twist. I’ve seen ads – you may have, too – that offer an item as “Now Only $2.49,” then in smaller type under that price are elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip he words “After This Sale $3.29,” or something similar. Credibility? When it comes to many retailers, credibility is almost as hard to find as the proverbial needle in a hay stack tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Be Careful What You Wish For – When Having a Large Benefactor is Not a Good Thing Going Public: How Long Does it Take? The Highly Skilled Migrant Programme [HSMP] - Employment Without Boundaries
|